During the past decade, Evergreen Health conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Evergreen Health" #1 collaborator was "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Evergreen Health" are "HIV-1 Infection" (1 trials) and "HIV-1-infection" (1 trials). Many other conditions were trialed in "Evergreen Health" in a lesser frequency.

Most popular intervention types in "Evergreen Health" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "ABC/DTG/3TC" (1 trials), "ABC/DTG/3TC Placebo" (1 trials), "B/F/TAF" (1 trials), "B/F/TAF Placebo" (1 trials) and "Bictegravir/Emtricitabine/Tenofovir Alafenamide 50 MG-200 MG-25 MG Oral Tablet [BIKTARVY]" (1 trials). Other intervention names were less common.

The vast majority of trials in "Evergreen Health" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Evergreen Health". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Evergreen Health, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Evergreen Health, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".